As of 2026-05-26, the EV/EBITDA ratio of Hyphens Pharma International Ltd (1J5.SI) is 6.68. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 1J5.SI's latest enterprise value is 83.08 mil SGD. 1J5.SI's TTM EBITDA according to its financial statements is 12.44 mil SGD. Dividing these 2 quantities gives us the above 1J5.SI EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 6.6x - 6.9x | 6.7x |
| Forward P/E multiples | 6.4x - 9.6x | 7.4x |
| Fair Price | 0.29 - 0.40 | 0.33 |
| Upside | -11.7% - 23.9% | 0.0% |
| Date | EV/EBITDA |
| 2026-05-25 | 6.68 |
| 2026-05-22 | 6.68 |
| 2026-05-21 | 6.56 |
| 2026-05-20 | 6.56 |
| 2026-05-19 | 6.68 |
| 2026-05-18 | 6.43 |
| 2026-05-15 | 6.68 |
| 2026-05-14 | 6.80 |
| 2026-05-13 | 6.80 |
| 2026-05-12 | 7.05 |
| 2026-05-11 | 6.93 |
| 2026-05-08 | 6.93 |
| 2026-05-07 | 7.05 |
| 2026-05-06 | 7.05 |
| 2026-05-05 | 7.43 |
| 2026-05-04 | 7.43 |
| 2026-04-30 | 7.30 |
| 2026-04-29 | 7.30 |
| 2026-04-28 | 7.18 |
| 2026-04-27 | 7.30 |
| 2026-04-24 | 7.43 |
| 2026-04-23 | 7.05 |
| 2026-04-22 | 6.93 |
| 2026-04-21 | 6.80 |
| 2026-04-20 | 6.80 |
| 2026-04-17 | 6.68 |
| 2026-04-16 | 6.56 |
| 2026-04-15 | 6.56 |
| 2026-04-14 | 6.56 |
| 2026-04-13 | 6.56 |
| 2026-04-10 | 6.68 |
| 2026-04-08 | 6.56 |
| 2026-04-07 | 6.18 |
| 2026-04-06 | 6.06 |
| 2026-04-02 | 6.18 |
| 2026-04-01 | 6.43 |
| 2026-03-31 | 6.31 |
| 2026-03-27 | 6.43 |
| 2026-03-26 | 6.43 |
| 2026-03-25 | 6.43 |
| 2026-03-24 | 6.31 |
| 2026-03-23 | 6.31 |
| 2026-03-20 | 6.56 |
| 2026-03-19 | 6.31 |
| 2026-03-18 | 6.56 |
| 2026-03-17 | 6.56 |
| 2026-03-16 | 6.31 |
| 2026-03-11 | 6.31 |
| 2026-03-10 | 6.56 |
| 2026-03-09 | 6.43 |